Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.112NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.370NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.118NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.137NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.309NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.632NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.108NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.332NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.411NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.109NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.361NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.417NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.430NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.331NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.112.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.515NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.287NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.431NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.170NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.506NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.188NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N/ANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.357NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used